CD44 and neoplasm: Furthermore, TGFβ inhibitor significantly retarded tumour formation, while reducing cell migration and invasion abilities, tumour mass, and the number of metastatic foci derived from orthotopically implanted ALDH+ CD44+ CXCR4+ CD24+ subpopulation (Supplementary Fig. 3B–F).